Limits...
Activated Leukocyte Cell Adhesion Molecule (ALCAM) in Saudi Breast Cancer Patients as Prognostic and Predictive Indicator.

Al-Shehri FS, Abd El Azeem EM - Breast Cancer (Auckl) (2015)

Bottom Line: Tumour markers CEA, CA 15-3 and s ALCAM levels were determined and Group 2 consisted of breast cancer patients.A highly significant elevation was recorded in s ALCAM, CA 15-3 and CEA.Percent change for grade II and grade III were [sALCAM (90, 127)], [CA15-3 (40, 72)] and [CEA (33, 156)].

View Article: PubMed Central - PubMed

Affiliation: Chemistry Department, Biochemistry, Science College, University of Dammam, Dammam, Saudi Arabia.

ABSTRACT

Background: Activated leukocyte cell adhesion molecules (ALCAMs) play an essential role in tumor metastasis and are higher in some patients with breast cancer.

Aim: This study aimed to evaluate ALCAM as an early diagnostic biomarker for breast cancer and how it compares with other markers.

Subjects and methods: One-hundred and sixty-one women were selected for this study. They were divided into three groups: Group 1 consisted of 42 healthy individuals (control) while a patients groups divided into two groups according to tumour grade, Group II, Include 58 breast cancer patient's grade II and Group III, Include 61 patients with grade III of breast cancer. Tumour markers CEA, CA 15-3 and s ALCAM levels were determined and Group 2 consisted of breast cancer patients.

Results: A highly significant elevation was recorded in s ALCAM, CA 15-3 and CEA. Percent change for grade II and grade III were [sALCAM (90, 127)], [CA15-3 (40, 72)] and [CEA (33, 156)]. Operating characteristic (ROC) curves were used to evaluate the diagnostic performance of the biomarkers ALCAM, CA15-3 and CEA with area under the curve (AUC) of (0.99 & 1.0) (AUC 0.947 & 0.99) and (AUC 0.88 & 0.94) for grade II and grade III respectively the incremental values of AUC were statistically highly significant (p < 0.001).

Conclusion: It could be concluded that serum ALCAM concentration represents a suitable biomarker for Saudi arabian breast carcinoma with high sensitivity and has the potential to be used as a diagnostic tool comparable to CA15-3 and CEA.

No MeSH data available.


Related in: MedlinePlus

ROC curve of ALCAM, CA 15-3 and CEA in Grade III.
© Copyright Policy - open-access
Related In: Results  -  Collection


getmorefigures.php?uid=PMC4581788&req=5

f3-bcbcr-9-2015-081: ROC curve of ALCAM, CA 15-3 and CEA in Grade III.

Mentions: The results in (Table 4) and (Fig. 3) provide the highest specificity and sensitivity of ALCAM with an AUC of 1.0 (P < 0.001) and cut of value of 79. The AUC for CA15-3 and CEA were 0.99 and 0.94, cut off values were 23.1 and 4.5 respectively.


Activated Leukocyte Cell Adhesion Molecule (ALCAM) in Saudi Breast Cancer Patients as Prognostic and Predictive Indicator.

Al-Shehri FS, Abd El Azeem EM - Breast Cancer (Auckl) (2015)

ROC curve of ALCAM, CA 15-3 and CEA in Grade III.
© Copyright Policy - open-access
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC4581788&req=5

f3-bcbcr-9-2015-081: ROC curve of ALCAM, CA 15-3 and CEA in Grade III.
Mentions: The results in (Table 4) and (Fig. 3) provide the highest specificity and sensitivity of ALCAM with an AUC of 1.0 (P < 0.001) and cut of value of 79. The AUC for CA15-3 and CEA were 0.99 and 0.94, cut off values were 23.1 and 4.5 respectively.

Bottom Line: Tumour markers CEA, CA 15-3 and s ALCAM levels were determined and Group 2 consisted of breast cancer patients.A highly significant elevation was recorded in s ALCAM, CA 15-3 and CEA.Percent change for grade II and grade III were [sALCAM (90, 127)], [CA15-3 (40, 72)] and [CEA (33, 156)].

View Article: PubMed Central - PubMed

Affiliation: Chemistry Department, Biochemistry, Science College, University of Dammam, Dammam, Saudi Arabia.

ABSTRACT

Background: Activated leukocyte cell adhesion molecules (ALCAMs) play an essential role in tumor metastasis and are higher in some patients with breast cancer.

Aim: This study aimed to evaluate ALCAM as an early diagnostic biomarker for breast cancer and how it compares with other markers.

Subjects and methods: One-hundred and sixty-one women were selected for this study. They were divided into three groups: Group 1 consisted of 42 healthy individuals (control) while a patients groups divided into two groups according to tumour grade, Group II, Include 58 breast cancer patient's grade II and Group III, Include 61 patients with grade III of breast cancer. Tumour markers CEA, CA 15-3 and s ALCAM levels were determined and Group 2 consisted of breast cancer patients.

Results: A highly significant elevation was recorded in s ALCAM, CA 15-3 and CEA. Percent change for grade II and grade III were [sALCAM (90, 127)], [CA15-3 (40, 72)] and [CEA (33, 156)]. Operating characteristic (ROC) curves were used to evaluate the diagnostic performance of the biomarkers ALCAM, CA15-3 and CEA with area under the curve (AUC) of (0.99 & 1.0) (AUC 0.947 & 0.99) and (AUC 0.88 & 0.94) for grade II and grade III respectively the incremental values of AUC were statistically highly significant (p < 0.001).

Conclusion: It could be concluded that serum ALCAM concentration represents a suitable biomarker for Saudi arabian breast carcinoma with high sensitivity and has the potential to be used as a diagnostic tool comparable to CA15-3 and CEA.

No MeSH data available.


Related in: MedlinePlus